Open AccessAre phosphodiesterase Type 5 inhibitors potential therapies for Alzheimer’s disease and related dementias?
Author(s) -
Danielle Newby
Publication year - 2022
Publication title -
brain communications
Language(s) - English
Resource type - Journals
ISSN - 2632-1297
DOI - 10.1093/braincomms/fcac260
Subject(s) - phosphodiesterase , alzheimer's disease , disease , pharmacology , medicine , neuroscience , chemistry , biochemistry , biology , enzyme
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom